Table 3. Keratotic skin lesions are associated with skin cancer.
No skin cancer | Squamous-cell carcinoma (with or without BCC) | Basal-cell carcinoma (with no SCC) | |||||
---|---|---|---|---|---|---|---|
Non-adjusted OR | Adjusted OR2 | Non-adjusted OR | Adjusted OR2 | ||||
1–49 vs 0 (95% CI) | 1–49 vs 0 (95% CI) | 1–49 vs 0 (95% CI) | 1–49 vs 0 (95% CI) | ||||
All countries together1 | N=557 | N=222 | 50 + vs 0 (95% CI) | 50 + vs 0 (95% CI) | N=131 | 50 + vs 0 (95% CI) | 50 + vs 0 (95% CI) |
Keratotic skin lesions3 | N (%) | N (%) | N (%) | ||||
0 | 267 (47.9) | 26 (11.7) | 34 (26.0) | ||||
1–49 | 231 (41.5) | 115 (51.8) | 5.1 (3.2;8.1) | 4.1 (2.4;7.0) | 79 (60.3) | 2.7 (1.7;4.2) | 2.9 (1.7;4.9) |
50–99 | 25 (4.5) | 25 (11.3) | 14.1 (8.3;24) | 12.1 (6.1;24) | 5 (3.8) | 1.4 (1.3;4.5) | 4.0 (1.7;9.2) |
100 and more | 34 (6.1) | 56 (25.2) | 13 (9.9) |
BCC, basal-cell carcinoma; SCC, squamous-cell carcinoma.
The data for the five countries are provided separately in Table S3.
Adjusted for age, sex, years after transplantation and study center.
Keratotic skin lesions consist of actinic keratoses, seborrheic warts, and hyperkeratotic papillomas.